Telegram Group & Telegram Channel
两部门:支持医保数据用于创新药研发

支持医保数据用于创新药研发,加强医疗、医保、医药信息互通与协同,在确保数据安全和合法合规基础上,探索为创新药研发提供必要的医保数据服务。依托全国统一的医保信息平台,归集分析疾病谱和临床用药需求,开发适配创新药研发的数据产品,助力医药企业、科研院所和医疗机构合理确定研发方向,提升创新效率。

媒体报道
两部门:支持医保数据用于创新药研发 36Kr
两部门:加强药品目录准入政策指导 财联社/钛媒体/格隆汇

事件追踪
2025-07-01 商保创新药目录首次纳入医保调整方案
2025-06-26 2025年基本医保目录及商保创新药目录调整申报操作指南出炉 首度纳入商保创新药目录
2025-06-17 国家医保局:每天约500万人次通过药品追溯码查验药品真伪
2025-05-29 国家医保局:已累计采集药品追溯信息392.36亿条
2025-05-28 国家医保局:对定点零售药店药师“挂证”开展核查
2025-04-21 国家卫生健康委:引进优质医疗资源 推进商业健康保险支持外资医疗机构发展
2025-04-09 医保码监管升级守护基金安全 我国拥有医药制造相关企业超过10.6万家
2025-03-01 国家医保局副局长李滔赴重庆调研医疗保障相关工作
2025-01-23 国家医保局:建立医保数据工作组更好赋能医疗机构发展
2025-01-13 国家医保局:拓宽创新药支付渠道,探索建立丙类药品目录

#热门话题



tg-me.com/readhub_cn/273702
Create:
Last Update:

两部门:支持医保数据用于创新药研发

支持医保数据用于创新药研发,加强医疗、医保、医药信息互通与协同,在确保数据安全和合法合规基础上,探索为创新药研发提供必要的医保数据服务。依托全国统一的医保信息平台,归集分析疾病谱和临床用药需求,开发适配创新药研发的数据产品,助力医药企业、科研院所和医疗机构合理确定研发方向,提升创新效率。

媒体报道
两部门:支持医保数据用于创新药研发 36Kr
两部门:加强药品目录准入政策指导 财联社/钛媒体/格隆汇

事件追踪
2025-07-01 商保创新药目录首次纳入医保调整方案
2025-06-26 2025年基本医保目录及商保创新药目录调整申报操作指南出炉 首度纳入商保创新药目录
2025-06-17 国家医保局:每天约500万人次通过药品追溯码查验药品真伪
2025-05-29 国家医保局:已累计采集药品追溯信息392.36亿条
2025-05-28 国家医保局:对定点零售药店药师“挂证”开展核查
2025-04-21 国家卫生健康委:引进优质医疗资源 推进商业健康保险支持外资医疗机构发展
2025-04-09 医保码监管升级守护基金安全 我国拥有医药制造相关企业超过10.6万家
2025-03-01 国家医保局副局长李滔赴重庆调研医疗保障相关工作
2025-01-23 国家医保局:建立医保数据工作组更好赋能医疗机构发展
2025-01-13 国家医保局:拓宽创新药支付渠道,探索建立丙类药品目录

#热门话题

BY Readhub


Warning: Undefined variable $i in /var/www/tg-me/post.php on line 283

Share with your friend now:
tg-me.com/readhub_cn/273702

View MORE
Open in Telegram


Readhub Telegram | DID YOU KNOW?

Date: |

The STAR Market, as is implied by the name, is heavily geared toward smaller innovative tech companies, in particular those engaged in strategically important fields, such as biopharmaceuticals, 5G technology, semiconductors, and new energy. The STAR Market currently has 340 listed securities. The STAR Market is seen as important for China’s high-tech and emerging industries, providing a space for smaller companies to raise capital in China. This is especially significant for technology companies that may be viewed with suspicion on overseas stock exchanges.

Should You Buy Bitcoin?

In general, many financial experts support their clients’ desire to buy cryptocurrency, but they don’t recommend it unless clients express interest. “The biggest concern for us is if someone wants to invest in crypto and the investment they choose doesn’t do well, and then all of a sudden they can’t send their kids to college,” says Ian Harvey, a certified financial planner (CFP) in New York City. “Then it wasn’t worth the risk.” The speculative nature of cryptocurrency leads some planners to recommend it for clients’ “side” investments. “Some call it a Vegas account,” says Scott Hammel, a CFP in Dallas. “Let’s keep this away from our real long-term perspective, make sure it doesn’t become too large a portion of your portfolio.” In a very real sense, Bitcoin is like a single stock, and advisors wouldn’t recommend putting a sizable part of your portfolio into any one company. At most, planners suggest putting no more than 1% to 10% into Bitcoin if you’re passionate about it. “If it was one stock, you would never allocate any significant portion of your portfolio to it,” Hammel says.

Readhub from us


Telegram Readhub
FROM USA